We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Predominant Antibody Deficiency and Risk of Microscopic Colitis: a Nationwide Case–Control Study in Sweden

    Purpose 

    Predominant antibody deficiency (PAD) disorders, including common variable immunodeficiency (CVID), have been linked to increased risk of...

    Daniel V. DiGiacomo, Bjorn Roelstraete, ... Jonas F. Ludvigsson in Journal of Clinical Immunology
    Article Open access 10 May 2023
  2. Immunoglobulin Replacement Therapy During COVID-19 Pandemic: Practical and Psychological Impact in Patients with Antibody Deficiency

    Purpose

    The COVID-19 pandemic has impacted on how health services deliver care and the mental health of the population. Due to their clinical...

    Jesmeen Maimaris, Anjel O’Sullivan, ... Reem Elfeky in Journal of Clinical Immunology
    Article Open access 26 June 2023
  3. Clinical Validation of a Primary Antibody Deficiency Screening Algorithm for Primary Care

    Purpose

    The diagnostic delay of primary antibody deficiencies (PADs) is associated with increased morbidity, mortality, and healthcare costs....

    Marianne A. Messelink, Paco M. J. Welsing, ... Helen L. Leavis in Journal of Clinical Immunology
    Article Open access 16 September 2023
  4. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

    Background

    Vaccination prevents severe morbidity and mortality from COVID-19 in the general population. The immunogenicity and efficacy of SARS-CoV-2...

    Adrian M. Shields, Sian E. Faustini, ... Sinead Walder in Journal of Clinical Immunology
    Article Open access 14 April 2022
  5. PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells

    The differentiation of naive and memory B cells into antibody-secreting cells (ASCs) is a key feature of adaptive immunity. The requirement for...

    Stephen M. Lanahan, Lucas Yang, ... Carrie L. Lucas in Nature Immunology
    Article 03 July 2024
  6. Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency

    Patients with primary antibody deficiency are at risk for severe and in many cases for prolonged COVID-19. Convalescent plasma treatment of...

    Julia Lang-Meli, Jonas Fuchs, ... Klaus Warnatz in Journal of Clinical Immunology
    Article Open access 10 December 2021
  7. Antibody Deficiency in Patients with Biallelic KARS1 Mutations

    Biallelic KARS1 mutations cause KARS-related diseases, a rare syndromic condition encompassing central and peripheral nervous system impairment,...

    Francesco Saettini, Fabiola Guerra, ... Andrea Biondi in Journal of Clinical Immunology
    Article 28 September 2023
  8. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET)

    Background

    Despite immunoglobulin replacement (IgRT) therapy, some patients with primary antibody deficiency (PAD) continue to develop respiratory...

    Maha N. Syed, Carleigh Kutac, ... Joud Hajjar in Journal of Clinical Immunology
    Article 02 July 2022
  9. Common Variable Immunodeficiency, Hypogammaglobulinemia, and Specific Antibody Deficiency

    Antibody deficiencies are a group of primary immune deficiencies caused by defects in B-cell development, B-cell activation, or antibody synthesis....
    Heather K. Lehman, Parteet Sandhu in Primary and Secondary Immunodeficiency
    Chapter 2021
  10. Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency

    Immunocompromised patients, including those with inborn errors of immunity (IEI), may be at increased risk for severe or prolonged infections with...

    Hannah Kinoshita, Jessica Durkee-Shock, ... Michael D. Keller in Journal of Clinical Immunology
    Article 13 May 2021
  11. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy

    Background

    There is growing evidence that antibody responses play a role in the resolution of SARS-CoV-2 infection. Patients with primary or secondary...

    Yusri Taha, Hayley Wardle, ... Christopher J. A. Duncan in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 30 December 2021
  12. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency

    Immune responses to coronavirus disease 2019 (COVID-19) mRNA vaccines in primary antibody deficiencies (PADs) are largely unknown. We investigated...

    Junghee Jenny Shin, Jennefer Par-Young, ... Insoo Kang in Journal of Clinical Immunology
    Article 17 June 2022
  13. ADAMTS13 Antibody and Inhibitor Assays

    A finding of an ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif, member 13) activity level of <10% of normal is...
    Gary W. Moore, Helga Vetr, Nikolaus B. Binder in Hemostasis and Thrombosis
    Protocol 2023
  14. Selective deficiency of UCP-1 and adropin may lead to different subtypes of anti-neutrophil cytoplasmic antibody-associated vasculitis

    Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease that is prone to respiratory and renal...

    Qingquan Chen, Youzhu Li, ... Qicai Liu in Genes & Immunity
    Article 20 January 2023
  15. Antibody-Based Biotherapeutics in Inflammatory Diseases

    Inflammatory diseases encompass a broad and diverse spectrum of serious chronic disorders, many of which have significant need for safe and effective...
    Yan Xu, Jia Chen, Honghui Zhou in Pharmaceutical Biotechnology
    Chapter 2024
  16. Impaired Response to Polysaccharide Vaccine in Selective IgE Deficiency

    Purpose

    Immunoglobulin E deficiency (IgED) (defined as IgE < 2 IU/mL) is enriched in patients with primary antibody deficiency (PAD). We hypothesized...

    Emily Noonan, Matthew D. Straesser, ... Monica G. Lawrence in Journal of Clinical Immunology
    Article 12 May 2023
  17. SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine

    Purpose

    CD8 cytotoxic T cells (CTLs) play a critical role in the clearance of virally infected cells. SARS-CoV-2-specific CD8 T cells and functional...

    Sudhir Gupta, Sudhanshu Agrawal, ... Yesim Demirdag in Journal of Clinical Immunology
    Article 02 April 2022
  18. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Cancer

    Antibody-dependet cell mediated cytotoxicity is a well known strategy to kill dangerous cells. Some antibody have the potential to bind IgG Fc...
    Matteo Paccagnella, Andrea Abbona, ... Ornella Garrone in Handbook of Cancer and Immunology
    Living reference work entry 2023
  19. CTLA4-Ig Effectively Controls Clinical Deterioration and Immune Condition in a Murine Model of Foxp3 Deficiency

    Purpose

    FOXP3 deficiency results in severe multisystem autoimmunity in both mice and humans, driven by the absence of functional regulatory T cells....

    Margaux Gerbaux, Evelyne Roos, ... Adrian Liston in Journal of Clinical Immunology
    Article Open access 08 May 2023
Did you find what you were looking for? Share feedback.